...
首页> 外文期刊>Circulation. Genomic and precision medicine. >Patient and Clinician Perceptions of Precision Cardiology Care: Findings From the HeartCare Study
【24h】

Patient and Clinician Perceptions of Precision Cardiology Care: Findings From the HeartCare Study

机译:Patient and Clinician Perceptions of Precision Cardiology Care: Findings From the HeartCare Study

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Routine genome-wide screening for cardiovascular disease risk may inform clinical decision-making. However, little is known about whether clinicians and patients would find such testing useful or acceptable within the context of a genomics-enabled learning health system.METHODS: We conducted surveys with patients and their clinicians who were participating in the HeartCare Study, a precision cardiology care project that returned results from a next-generation sequencing panel of 158 genes associated with cardiovascular disease risk. Six weeks after return of results, we assessed patients' and clinicians' perceived utility and disutility of HeartCare, the effect of the test on clinical recommendations, and patients' attitudes toward integration of research and clinical care.RESULTS: Among 666 HeartCare patients with a result returned during the survey study period, 42.0% completed a full or partial survey. Patient-participants who completed a full survey (n=224) generally had positive perceptions of HeartCare independent of whether they received a positive or negative result. Most patient-participants considered genetic testing for cardiovascular disease risk to have more benefit than risk (88.3%) and agreed that it provided information that they wanted to know (81.2%), while most disagreed that the test caused them to feel confused (77.7%) or overwhelmed (78.0%). For 122 of their patients with positive results, clinicians (n=13) reported making changes in clinical care for 66.4% of patients, recommending changes in health behaviors for 36.9% of patients, and recommending to 33.6% of patients that their family members have clinical testing.CONCLUSIONS: Both patients and clinicians thought the HeartCare panel screen for cardiovascular disease risk provided information that was useful in terms of personal or health benefits to the patient and that informed clinical care without causing patients to be confused or overwhelmed. Further research is needed to assess perceptions of genome-wide screening among the US cardiology clinic population.
机译:背景:常规全基因组筛查可能通知临床心血管疾病风险决策。临床医生和患者是否会找到这样的测试有用的或可接受的上下文中genomics-enabled学习的健康系统。病人和他们的医生参与HeartCare研究精度心脏病护理项目,返回的结果158年从下一代测序面板基因与心血管疾病有关风险。评估患者和临床医生的感知HeartCare效用和负效用,效果临床试验的建议病人的态度的整合研究和临床护理。HeartCare患者期间返回结果调查研究期间,完成一个完整的42.0%或部分调查。通常完成一个完整的调查(n = 224)积极HeartCare独立的观念他们是否收到了积极的还是消极的结果。心血管疾病风险的基因测试好处大于风险(88.3%)和同意它提供他们想要的信息知道(81.2%),而大多数不同意测试使他们感到困惑(77.7%)或了(78.0%)。用积极的结果,临床医生(n = 13)报道更改为66.4%的临床护理患者,推荐健康的变化36.9%的病人的行为,建议33.6%的患者,他们的家庭成员有临床测试。和临床医生认为HeartCare屏幕面板心血管疾病风险个人信息是有用的病人或健康的好处了解临床护理不会引起病人混淆或不知所措。需要评估的看法全基因组筛选在美国心脏病学诊所人口。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号